These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 16550931)
21. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. Lennon NJ; Kho A; Bacskai BJ; Perlmutter SL; Hyman BT; Brown RH J Biol Chem; 2003 Dec; 278(50):50466-73. PubMed ID: 14506282 [TBL] [Abstract][Full Text] [Related]
22. Dysferlin expression in tubular aggregates: their possible relationship to endoplasmic reticulum stress. Ikezoe K; Furuya H; Ohyagi Y; Osoegawa M; Nishino I; Nonaka I; Kira J Acta Neuropathol; 2003 Jun; 105(6):603-9. PubMed ID: 12664320 [TBL] [Abstract][Full Text] [Related]
23. Characterization of a multiprotein complex involved in excitation-transcription coupling of skeletal muscle. Arias-Calderón M; Almarza G; Díaz-Vegas A; Contreras-Ferrat A; Valladares D; Casas M; Toledo H; Jaimovich E; Buvinic S Skelet Muscle; 2016; 6():15. PubMed ID: 27069569 [TBL] [Abstract][Full Text] [Related]
24. The C2 domains of dysferlin: roles in membrane localization, Ca Muriel J; Lukyanenko V; Kwiatkowski T; Bhattacharya S; Garman D; Weisleder N; Bloch RJ J Physiol; 2022 Apr; 600(8):1953-1968. PubMed ID: 35156706 [TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro dysferlin expression in human muscle satellite cells. De Luna N; Gallardo E; Illa I J Neuropathol Exp Neurol; 2004 Oct; 63(10):1104-13. PubMed ID: 15535137 [TBL] [Abstract][Full Text] [Related]
26. Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release. Zacharias U; Purfürst B; Schöwel V; Morano I; Spuler S; Haase H J Muscle Res Cell Motil; 2011 Dec; 32(4-5):271-80. PubMed ID: 22057634 [TBL] [Abstract][Full Text] [Related]
27. Membrane damage-induced vesicle-vesicle fusion of dysferlin-containing vesicles in muscle cells requires microtubules and kinesin. McDade JR; Michele DE Hum Mol Genet; 2014 Apr; 23(7):1677-86. PubMed ID: 24203699 [TBL] [Abstract][Full Text] [Related]
28. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy. Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057 [TBL] [Abstract][Full Text] [Related]
29. Rapid actin-cytoskeleton-dependent recruitment of plasma membrane-derived dysferlin at wounds is critical for muscle membrane repair. McDade JR; Archambeau A; Michele DE FASEB J; 2014 Aug; 28(8):3660-70. PubMed ID: 24784578 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle. Guo LT; Moore SA; Forcales S; Engvall E; Shelton GD Neuromuscul Disord; 2010 Dec; 20(12):820-5. PubMed ID: 20817457 [TBL] [Abstract][Full Text] [Related]
31. Variable reduction of caveolin-3 in patients with LGMD2B/MM. Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575 [TBL] [Abstract][Full Text] [Related]
32. Symptomatic dysferlin gene mutation carriers: characterization of two cases. Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450 [TBL] [Abstract][Full Text] [Related]
33. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B. Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735 [TBL] [Abstract][Full Text] [Related]
34. Dysferlin and the plasma membrane repair in muscular dystrophy. Bansal D; Campbell KP Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638 [TBL] [Abstract][Full Text] [Related]
36. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells. Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392 [TBL] [Abstract][Full Text] [Related]
37. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3. Hernández-Deviez DJ; Martin S; Laval SH; Lo HP; Cooper ST; North KN; Bushby K; Parton RG Hum Mol Genet; 2006 Jan; 15(1):129-42. PubMed ID: 16319126 [TBL] [Abstract][Full Text] [Related]
38. Expression levels of sarcolemmal membrane repair proteins following prolonged exercise training in mice. Alloush J; Roof SR; Beck EX; Ziolo MT; Weisleder N Indian J Biochem Biophys; 2013 Oct; 50(5):428-35. PubMed ID: 24772964 [TBL] [Abstract][Full Text] [Related]
39. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828 [TBL] [Abstract][Full Text] [Related]
40. Analysis of Dysferlin Direct Interactions with Putative Repair Proteins Links Apoptotic Signaling to Ca Drescher DG; Drescher MJ; Selvakumar D; Annam NP Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]